Gene expression profiling predicts clinical outcome of breast cancer

McGuire, W. L. Breast cancer prognostic factors: evaluation guidelines. J. Natl Cancer Inst. 83, 154–155 (1991).

Goldhirsch, A., Glick, J. H., Gelber, R. D. & Senn, H. J. Meeting highlights: international consensus panel on the treatment of primary breast cancer. J. Natl Cancer Inst. 90, 1601–1608 (1998).

Eifel, P. et al. National institutes of health consensus development conference statement: adjuvant therapy for breast cancer, November 1–3, 2000. J. Natl Cancer Inst. 93, 979–989 (2001).

Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 352, 930–942 (1998).

Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351, 1451–1467 (1998).

Perou, C. M. et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl Acad. Sci. USA 96, 9212–9217 (1999).

Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747–752 (2000).

Gruvberger, S. et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 61, 5979–5984 (2001).

Martin, K. J. et al. Linking gene expression patterns to therapeutic groups in breast cancer. Cancer Res. 60, 2232–2238 (2000).

Zajchowski, D. A. et al. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res. 61, 5168–5178 (2001).

Sorlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA 98, 10869–10874 (2001).

West, M. et al. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc. Natl Acad. Sci. USA 98, 11462–11467 (2001).

Hughes, T. R. et al. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nature Biotechnol. 19, 342–347 (2001).

Roberts, C. J. et al. Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles. Science 287, 873–880 (2000).

Lakhani, S. R. et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J. Natl Cancer Inst. 90, 1138–1145 (1998).

Brenton, J. D., Aparicio, S. A. & Caldas, C. Molecular profiling of breast cancer: portraits but not physiognomy. Breast Cancer Res. 3, 77–80 (2001).

Khan, J. et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Naure Med. 7, 673–679 (2001).

He, Y. D. & Friend, S. H. Microarrays—the 21st century divining rod? Nature Med. 7, 658–659 (2001).

Bieche, I. et al. Genetic alterations in breast cancer. Genes Chromosomes Cancer 14, 227–251 (1995).

Steeg, P. S. & Zhou, Q. Cyclins and breast cancer. Breast Cancer Res. Treat. 52, 17–28 (1998).

Janicke, F. et al. Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1. J. Natl Cancer Inst. 93, 913–920 (2001).

van Diest, P. J. et al. Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. Am. J. Pathol. 150, 705–711 (1997).

Zheng, L., Annab, L. A., Afshari, C. A., Lee, W. H. & Boyer, T. G. BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor. Proc. Natl Acad. Sci. USA 98, 9587–9592 (2001).

Esteller, M. et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J. Natl Cancer Inst. 92, 564–569 (2000).

Chapman, M. S. & Verma, I. M. Transcriptional activation by BRCA1. Nature 382, 678–679 (1996).

Hedenfalk, I. et al. Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med. 344, 539–548 (2001).